logo

For the Inventor, By the Inventor

Pittsburgh, PA, United States of America

Jennifer Rubin Grandis

This inventor holds 11 USPTO granted patents and 1 published patent application. Top assignees: University of Pittsburgh, Carnegie Mellon University, Eye & Ear Foundation. Active years: 2000-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jennifer Rubin Grandis. Retrieved from https://idiyas.com/inventor/jennifer-rubin-grandis

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 11 

% Patents Active = 90.9

Average Co-Inventor Count = 2.8

ph-index = 4

Forward Citations = 31(Granted Patents)


Company Filing History:

goldMedal9 out of 1,963 
 
University of Pittsburgh
 patents
silverMedal2 out of 1,190 
 
Carnegie Mellon University
 patents
bronzeMedal2 out of 2 
 
Eye & Ear Foundation
 patents
4. 1 out of 1,269 
 
Dana-Farber-Cancer Institute Inc.
 patents
5. 1 out of 3,081 
 
Harvard College
 patents
6. 1 out of 15 
 
Instituto Carlos Slim De La Salud, A.c.
 patents
7. 1 out of 276 
 
Massachusetts Eye and Ear Infirmary
 patents
8. 1 out of 8,600 
 
Massachusetts Institute of Technology
 patents
9. 1 out of 490 
 
The Broad Institute, Inc.
 patents
10. 1 out of 834,601 
Other
 patents
where one patent can have more than one assignee

Years Active: 2000-2021

Loading Chart...
11 patents (USPTO):Explore Patents
1. 11111253 - 6-aryl-7-substituted-3-(1H-pyrazol-5-yl)-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazines as inhibitors of the STAT3 pathway with anti-proliferative activity (2021-09-07),
2. 10618914 - 6-aryl-7-substituted-3-(1H-pyrazol-5-yl)-7H-[1,2,4]triazolo[3,4-B][1,3,4]thiadiazines as inhibitors of the STAT3 pathway with anti-proliferative activity (2020-04-14),
3. 10183977 - Stabilized STAT3 decoy oligonucleotides and uses therefor (2019-01-22),
4. 9926605 - Functional genomics screening platform for head and neck cancer (2018-03-27),
5. 9370551 - Compositions and methods of treating head and neck cancer (2016-06-21),
6. 9334496 - Antisense EGFRAS guanidinium peptide nucleic acid (GPNA) oligonucleotides as antitumor agents (2016-05-10),
7. 9062121 - Stabilized STAT3 decoy oligonucleotides and uses therefore (2015-06-23),
8. 8722640 - Stabilized STAT3 decoy oligonucleotides and uses therefor (2014-05-13),
9. 7960360 - Antisense guanidinium peptide nucleic acid (GPNA) oligonucleotides as antitumor agents (2011-06-14),
10. 7662793 - Inhibition of human squamous cell carcinoma growth in vivo by epidermal growth factor receptor antisense RNA transcribed from a Pol III promoter (2010-02-16),
11. 6063586 - Diagnostic protocol (2000-05-16),

Title: Inventor Jennifer Rubin Grandis: Innovations in Cancer Treatment

Introduction

Jennifer Rubin Grandis, a noted inventor based in Pittsburgh, PA, has made significant contributions to the field of medical science, specifically in cancer treatment. With a remarkable portfolio of 11 patents, her innovative work focuses on the STAT3 pathway and its implications in cancer therapy.

Latest Patents

Among her latest patents, Jennifer has developed compounds such as "6-aryl-7-substituted-3-(1H-pyrazol-5-yl)-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazines" which serve as selective inhibitors of the STAT3 pathway while not affecting the STAT1 pathway. These compounds exhibit anti-proliferative activity, providing safer methods of treatment for cancers characterized by overexpression of STAT3, thus paving the way for therapeutic advancements that minimize adverse effects associated with traditional therapies.

Career Highlights

Jennifer has been affiliated with esteemed institutions including the University of Pittsburgh and the Eye & Ear Foundation. Her work in these organizations has allowed her to further her research and develop patented solutions targeting critical health challenges.

Collaborations

Throughout her career, Jennifer has collaborated with notable colleagues such as Danith H. Ly and Daniel E. Johnson. These partnerships have fostered a collaborative approach in her innovative endeavors, contributing to significant advancements in her field.

Conclusion

Jennifer Rubin Grandis stands as an influential figure in the realm of medical inventions, particularly concerning cancer treatment innovations. Her extensive contributions, characterized by her inventive patents, have the potential to positively impact the lives of many individuals facing cancer, solidifying her place as a vital inventor in contemporary science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…